Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2020 | 10-2019 | 07-2019 | 04-2019 | 01-2019 | |
| Sales | 0 | 0 | 0 | 250 | 0 |
| Gross Profit | N/A | N/A | N/A | 250 | N/A |
| Operating Expenses | 2,630 | 2,129 | 2,184 | 2,843 | 4,984 |
| Operating Income | -2,630 | -2,129 | -2,184 | -2,593 | -4,984 |
| Other Income | 13 | 18 | 18 | 18 | 17 |
| Pre-tax Income | -2,617 | -2,111 | -2,166 | -2,575 | -4,967 |
| Net Income Continuous | -2,617 | -2,111 | -2,166 | -2,575 | -4,967 |
| Minority Interests | -24 | -24 | -26 | -37 | -85 |
| Net Income | $-2,593 | $-2,088 | $-2,140 | $-2,538 | $-4,882 |
| EPS Basic Total Ops | -0.13 | -0.10 | -0.11 | -0.13 | -0.25 |
| EPS Basic Continuous Ops | -0.13 | -0.10 | -0.11 | -0.13 | -0.26 |
| EPS Diluted Total Ops | -0.13 | -0.10 | -0.11 | -0.13 | -0.25 |
| EPS Diluted Continuous Ops | -0.13 | -0.10 | -0.11 | -0.13 | -0.26 |
| EBITDA(a) | $-2,603 | $-2,114 | $-2,128 | $-2,456 | $-4,726 |